27
Aug

Just 8 months after extending its last round with a $15 million raise, Houston-based Bellicum Pharmaceuticals has lured in a whole new group of backers to add $55 million to fuel its work. And the strategic financing allows the biotech to stare down a shot at an IPO while the window remains open.

…read more

Source: Grabbing a quick $55M venture round, Bellicum Pharma ponders an IPO

    

0 No comments